Published on
April 9, 2026
- 17:13 GMT
Patients for Bitopertin Launches, Calls for Urgent Path Forward After FDA Delays Approval Decision
New patient-driven initiative amplifies the voices of people living with EPP and XLP, two rare diseases in which sunlight can cause severe phototoxic pain BETHESDA, MD, UNITED STATES, April 9, 2026 /EINPresswire.com/ -- Patients for Bitopertin, an …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Science
...
